3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
8
Phase 1
2
Phase NA
1
Status
Terminated
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Other hematologic neoplasm
2
Myeloid
2
Conditions
Myelodysplastic Syndromes
9
Leukemia, Myeloid, Acute
9
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Leukemia
4
Multiple Myeloma
3
Lymphoma
3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Hematologic Neoplasms
3
Primary Myelofibrosis
2
Lymphoma, Non-Hodgkin
2
Leukemia, Myelomonocytic, Juvenile
2
Hodgkin Disease
2
Waldenstrom Macroglobulinemia
1
Sarcoma, Ewing
1
Rhabdoid Tumor
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Philadelphia Chromosome
1
Pathologic Complete Response
1
Neuroectodermal Tumors, Primitive
1
Neuroblastoma
1
Myeloid Diseases
1
Myasthenia Gravis
1
Medulloblastoma
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, T-Cell
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Interventions
Cyclophosphamide
5
fludarabine
3
Clofarabine
3
thymoglobulin
2
fludarabine phosphate
2
Vorinostat
2
Polymerase Chain Reaction
2
Methotrexate
2
Isotretinoin
2
Gemtuzumab
2
Flow Cytometry
2
Busulfan
2
Azacitidine
2
Antilymphocyte Serum
2
tipifarnib
1
ruxolitinib
1
merphos
1
imetelstat
1
hydrocortisone hemisuccinate
1
cc-486
1
Whole-Body Irradiation
1
Topotecan
1
Thiotepa
1
Tacrolimus
1
Spinal Puncture
1
Specimen Handling
1
Radioimmunotherapy
1
N(alpha)-(4-amino-4-deoxypteroyl)-N(delta)-hemiphthaloyl-L-ornithine
1
Mycophenolic Acid
1
MK 2206
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 1
×
Leukemia, Myelomonocytic, Juvenile
×
thymoglobulin
×
Clear all
NCT01020539
2021-08-06
AML/MDS/JMML
Columbia University
Phase 1
Completed
18 enrolled
NCT00669890
2015-04-22
High Risk
New York Medical College
Phase 1
Terminated
12 enrolled